Developing a core outcome set for future infertility research: an international consensus development study† ‡
- PMID: 33252685
- PMCID: PMC7744160
- DOI: 10.1093/humrep/deaa241
Developing a core outcome set for future infertility research: an international consensus development study† ‡
Abstract
Study question: Can a core outcome set to standardize outcome selection, collection and reporting across future infertility research be developed?
Summary answer: A minimum data set, known as a core outcome set, has been developed for randomized controlled trials (RCTs) and systematic reviews evaluating potential treatments for infertility.
What is known already: Complex issues, including a failure to consider the perspectives of people with fertility problems when selecting outcomes, variations in outcome definitions and the selective reporting of outcomes on the basis of statistical analysis, make the results of infertility research difficult to interpret.
Study design, size, duration: A three-round Delphi survey (372 participants from 41 countries) and consensus development workshop (30 participants from 27 countries).
Participants/materials, setting, methods: Healthcare professionals, researchers and people with fertility problems were brought together in an open and transparent process using formal consensus science methods.
Main results and the role of chance: The core outcome set consists of: viable intrauterine pregnancy confirmed by ultrasound (accounting for singleton, twin and higher multiple pregnancy); pregnancy loss (accounting for ectopic pregnancy, miscarriage, stillbirth and termination of pregnancy); live birth; gestational age at delivery; birthweight; neonatal mortality; and major congenital anomaly. Time to pregnancy leading to live birth should be reported when applicable.
Limitations, reasons for caution: We used consensus development methods which have inherent limitations, including the representativeness of the participant sample, Delphi survey attrition and an arbitrary consensus threshold.
Wider implications of the findings: Embedding the core outcome set within RCTs and systematic reviews should ensure the comprehensive selection, collection and reporting of core outcomes. Research funding bodies, the Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT) statement, and over 80 specialty journals, including the Cochrane Gynaecology and Fertility Group, Fertility and Sterility and Human Reproduction, have committed to implementing this core outcome set.
Study funding/competing interest(s): This research was funded by the Catalyst Fund, Royal Society of New Zealand, Auckland Medical Research Fund and Maurice and Phyllis Paykel Trust. The funder had no role in the design and conduct of the study, the collection, management, analysis or interpretation of data, or manuscript preparation. B.W.J.M. is supported by a National Health and Medical Research Council Practitioner Fellowship (GNT1082548). S.B. was supported by University of Auckland Foundation Seelye Travelling Fellowship. S.B. reports being the Editor-in-Chief of Human Reproduction Open and an editor of the Cochrane Gynaecology and Fertility group. J.L.H.E. reports being the Editor Emeritus of Human Reproduction. J.M.L.K. reports research sponsorship from Ferring and Theramex. R.S.L. reports consultancy fees from Abbvie, Bayer, Ferring, Fractyl, Insud Pharma and Kindex and research sponsorship from Guerbet and Hass Avocado Board. B.W.J.M. reports consultancy fees from Guerbet, iGenomix, Merck, Merck KGaA and ObsEva. C.N. reports being the Co Editor-in-Chief of Fertility and Sterility and Section Editor of the Journal of Urology, research sponsorship from Ferring, and retains a financial interest in NexHand. A.S. reports consultancy fees from Guerbet. E.H.Y.N. reports research sponsorship from Merck. N.L.V. reports consultancy and conference fees from Ferring, Merck and Merck Sharp and Dohme. The remaining authors declare no competing interests in relation to the work presented. All authors have completed the disclosure form.
Trial registration number: Core Outcome Measures in Effectiveness Trials Initiative: 1023.
Keywords: Consensus development study; core outcome sets; modified Delphi method; modified Nominal Group Technique; outcome measures; outcomes.
© The Author(s) 2020. Published by Oxford University Press on behalf of European Society of Human Reproduction and Embryology.
Figures
Similar articles
-
Developing a core outcome set for future infertility research: an international consensus development study.Fertil Steril. 2021 Jan;115(1):191-200. doi: 10.1016/j.fertnstert.2020.11.012. Epub 2020 Nov 30. Fertil Steril. 2021. PMID: 33272618
-
Top 10 priorities for future infertility research: an international consensus development study† ‡.Hum Reprod. 2020 Dec 1;35(12):2715-2724. doi: 10.1093/humrep/deaa242. Hum Reprod. 2020. PMID: 33252677 Free PMC article.
-
Standardizing definitions and reporting guidelines for the infertility core outcome set: an international consensus development study† ‡.Hum Reprod. 2020 Dec 1;35(12):2735-2745. doi: 10.1093/humrep/deaa243. Hum Reprod. 2020. PMID: 33252643 Free PMC article.
-
Top 10 priorities for future infertility research: an international consensus development study.Fertil Steril. 2021 Jan;115(1):180-190. doi: 10.1016/j.fertnstert.2020.11.014. Epub 2020 Nov 30. Fertil Steril. 2021. PMID: 33272617
-
Standardizing definitions and reporting guidelines for the infertility core outcome set: an international consensus development study.Fertil Steril. 2021 Jan;115(1):201-212. doi: 10.1016/j.fertnstert.2020.11.013. Epub 2020 Nov 30. Fertil Steril. 2021. PMID: 33272619
Cited by
-
Time to live birth: towards a common agreement.J Assist Reprod Genet. 2023 May;40(5):997-1001. doi: 10.1007/s10815-023-02790-3. Epub 2023 Apr 18. J Assist Reprod Genet. 2023. PMID: 37071319 Free PMC article.
-
Long-term outcomes of switching to gonadotrophins versus continuing with clomiphene citrate, with or without intrauterine insemination, in women with normogonadotropic anovulation and clomiphene failure: follow-up study of a factorial randomized clinical trial.Hum Reprod. 2023 Mar 1;38(3):421-429. doi: 10.1093/humrep/deac268. Hum Reprod. 2023. PMID: 36622200 Free PMC article. Clinical Trial.
-
Expectant management versus IUI in unexplained subfertility and a poor pregnancy prognosis (EXIUI study): a randomized controlled trial.Hum Reprod. 2022 Nov 24;37(12):2808-2816. doi: 10.1093/humrep/deac236. Hum Reprod. 2022. PMID: 36331493 Free PMC article. Clinical Trial.
-
Should germline genome editing be allowed? The effect of treatment characteristics on public acceptability.Hum Reprod. 2021 Jan 25;36(2):465-478. doi: 10.1093/humrep/deaa212. Hum Reprod. 2021. PMID: 33242333 Free PMC article.
-
Trial characteristics, geographic distribution, and selected methodological issues of 1425 infertility trials published from 2012 to 2023: a systematic review.Hum Reprod Open. 2025 Jan 24;2025(1):hoaf004. doi: 10.1093/hropen/hoaf004. eCollection 2025. Hum Reprod Open. 2025. PMID: 39980657 Free PMC article. Review.
References
-
- Braakhekke M, Kamphuis EI, van Rumste MM, Mol F, van der Veen F, Mol BW. How are neonatal and maternal outcomes reported in randomised controlled trials (RCTs) in reproductive medicine? Hum Reprod 2014;29:1211–1217. - PubMed
-
- Core Outcomes in Women's and Newborn Health Initiative. The CROWN Initiative: journal editors invite researchers to develop core outcomes in women's health. Hum Reprod 2014;29:1349–1350. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials